Literature DB >> 1393038

Treatment with activated charcoal complicated by gastrointestinal obstruction requiring surgery.

S W Atkinson1, Y Young, G A Trotter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1393038      PMCID： PMC1883303          DOI： 10.1136/bmj.305.6853.563

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Role of repeated oral doses of activated charcoal in clinical toxicology.

Authors:  S M Pond
Journal:  Med Toxicol       Date:  1986 Jan-Feb

2.  Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man.

Authors:  P J Neuvonen; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

3.  Aspiration of activated charcoal and gastric contents.

Authors:  M M Pollack; B S Dunbar; P R Holbrook; A I Fields
Journal:  Ann Emerg Med       Date:  1981-10       Impact factor: 5.721

4.  Gastrointestinal obstruction associated with multiple-dose activated charcoal.

Authors:  W A Watson; K F Cremer; J A Chapman
Journal:  J Emerg Med       Date:  1986       Impact factor: 1.484
  4 in total
  2 in total

1.  Venlafaxine pharmacobezoar causing intestinal ischemia requiring emergent hemicolectomy.

Authors:  Derrick Lung; Cristina Cuevas; Uwais Zaid; Benedict Ancock
Journal:  J Med Toxicol       Date:  2011-09

2.  Gastrointestinal decontamination in the acutely poisoned patient.

Authors:  Timothy E Albertson; Kelly P Owen; Mark E Sutter; Andrew L Chan
Journal:  Int J Emerg Med       Date:  2011-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.